Update on Diabetic Kidney Disease

In this presentation, Dr. Sankar Dass Navaneethan, Associate Professor of Medicine in the Section of Nephrology at Baylor College of Medicine, discusses the growing burden of diabetic kidney disease (DKD), the effects on intensive glucose control on DKD, and the various management strategies for DKD. He explains the role of novel oral hypoglycemic agents, specifically SGLT2 inhibitors and GLP-1 receptor agonists,in slowing the development of microalbuminuria and proteinuria in diabetic patients. 

Dr. Navaneethan also describes the management of obesity in patients with DKD and highlights the need for a multidisciplinary team to manage DKD and its related comorbidities.

Target Audience

This CME/CE activity is designed to meet the educational needs of physicians, residents, fellows, and community providers.

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Discuss the burden and impact of diabetic kidney disease.

  • Evaluate the effects of intense glycemic control in patients with kidney disease.

  • Summarize emerging evidence on the use of novel hypoglycemic agents to manage diabetic kidney disease.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
08/01/2019
Course expires: 
08/31/2021
Rating: 
0

Richard J. Hamill, M.D., Planning Committee Member 
Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Erica Lescinskas, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Zaven Sargsyan, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Chirayu Shah, M.D., M.Ed., Planning Committee Member
Associate Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Stephanie Sherman, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Jefferson Triozzi, M.D., Planning Committee Member
Internal Medicine Resident
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.